IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 1216.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 31-Jul-2013
Proceedings of the National Academy of Sciences
Study offers promising new direction for organ regeneration and tissue repair
Researchers have identified an entirely new approach to enhance tissue growth, findings that could lead to advances in organ regeneration and tissue repair, with widespread therapeutic applications.
NIH/National Cancer Institute, National Institutes of Health, NIH/National Institute of Environmental Health Sciences, Robert A. Welch Foundation

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center

Public Release: 31-Jul-2013
Nature
New protein discovered with vast potential for treatment of cancer and other diseases
In cancer research, discovering a new protein that plays a role in cancer is like finding a key and a treasure map: follow the clues and eventually there could be a big reward. At least that's the hope from a new study published in the journal Nature that discovered a novel protein called ceramide-1 phosphate transport protein.
NIH/National Cancer Institute, Veterans Administration

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University

Public Release: 31-Jul-2013
Nature
Digest this: Cure for cancer may live in our intestines
Treating a cancerous tumor is like watering a houseplant with a fire hose -- too much water kills the plant, just as too much chemotherapy and radiation kills the patient before it kills the tumor.
National Institutes of Health

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan

Public Release: 31-Jul-2013
Nature
The naked mole-rat's secret to staying cancer free
A team of researchers from the University of Rochester (NY) and the University of Haifa discovered the naked mole rat's unique mechanism to staying cancer free- a super sugar called high-molecular-mass Hyaluronan (HMM-HA). When secreted by the naked mole rat's cells, this molecule prevents cells from overcrowding and forming tumors. Researchers now say using naked mole-rat HMM-HA in the clinic could open up new avenues for cancer prevention and life extension in humans.

Contact: Polina Petruhin
ppetruh1@univ.haifa.ac.il
972-482-88722
University of Haifa

Public Release: 30-Jul-2013
Radiology
Tomosynthesis reduces breast cancer screening recall rate
Digital tomosynthesis is an effective tool for reducing the recall rate in breast cancer screening, according to a new study.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 30-Jul-2013
Radiology
Some women with abnormal breast lesions may avoid surgery
Surgery is not always necessary for women with a type of breast tissue abnormality associated with a higher risk of cancer, according to a new study. Researchers said that periodic imaging and clinical exam are effective in these patients when radiology and pathology findings are benign and concordant, or in agreement.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 30-Jul-2013
PLOS Medicine
A new model can predict a woman's risk of breast, ovarian and womb cancer
The probability (absolute risk) of a woman developing breast, ovarian, and endometrial (womb) cancer can all be predicted using easily obtainable information on known risk factors for these cancers, according to a study by US researchers published in this week's PLOS Medicine.
NIH/National Cancer Institute

Contact: Fiona Godwin
fgodwin@plos.org
01-223-442-834
Public Library of Science

Public Release: 30-Jul-2013
Oncotarget
Sanford-Burnham researchers uncover how a potent compound kills prostate cancer cells
A new study spearheaded by researchers at Sanford-Burnham Medical Research Institute reveals how a promising anticancer compound called SMIP004 specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.
National Institutes of Health, US Department of the Army

Contact: Deborah Robison
drobison@sanfordburnham.org
407-615-0072
Sanford-Burnham Medical Research Institute

Public Release: 30-Jul-2013
Nature
UCLA and Chinese scientists analyze genetic makeup of human and mouse embryos in amazing detail
UCLA scientists and Chinese collaborators have used the powerful technology of single-cell RNA sequencing to track the genetic development of a human and a mouse embryo at an unprecedented level of accuracy. The success of this technique could lead to genetic diagnoses of diseases with higher resolution and in embryos earlier than ever achieved before, even when the embryo consists of only eight cells.

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles

Public Release: 30-Jul-2013
Genome Biology
Ancient viruses that function in early human development may play role in cancer
The St. Laurent Institute published a study in Genome Biology showing that novel non-coding parts of the human genome known as vlincRNAs (very long intergenic, non-coding RNAs) triggered by ancient viruses, participate in the biology of stem cells, and in the development of cancer. Importantly, the group of researchers from US, Europe and Russia found that the elimination of these vlincRNAs caused the death of cancer cells.
St. Laurent Institute

Contact: Stephanie Ashe
sashe@continuumhealthcom.com
650-245-0425
Continuum Health Communications

Public Release: 30-Jul-2013
Blood
Reprogramming patients' cells offers powerful new tool for studying, treating blood diseases
First produced only in the past decade, human induced pluripotent stem cells (iPSCs) are capable of developing into many or even all human cell types. In new research, scientists reprogrammed skin cells from patients with rare blood disorders into iPSCs, highlighting the great promise of these cells in advancing understanding of those challenging diseases -- and eventually in treating them.
National Institutes of Health

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia

Public Release: 29-Jul-2013
JAMA Internal Medicine
Decision aids reduce men's conflict about PSA screening, but don't change their decisions
Men who decide to be screened for prostate cancer and those who forgo PSA screening stick with their decisions after receiving materials explaining the risks and benefits of the test. The decision aids greatly increased their knowledge about screening and reduced their conflict about what to do, but did not have an impact on their screening decision when measured a year later.
NIH/National Cancer Institute, US Department of Defense

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 29-Jul-2013
Cancer
Higher cancer incidences found in regions near refineries and plants that release benzene
The incidence of a particular type of blood cancer is significantly higher in regions near facilities that release the chemical benzene into the environment. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. This and other studies like it will be critical to identifying and enacting public health policies to decrease or prevent cancer.

Contact: Amy Molnar
sciencenewsroom@wiley.com
Wiley

Public Release: 29-Jul-2013
Annals of Internal Medicine
Annals of Internal Medicine tip sheet for July 30, 2013
Below is information about an article being published in the July 30 issue of Annals of Internal Medicine. The information is not intended to substitute for the full article as a source of information. Annals of Internal Medicine attribution is required for all coverage.

Contact: Angela Collom
acollom@acponline.org
215-351-2653
American College of Physicians

Public Release: 29-Jul-2013
JAMA Internal Medicine
Decision aids associated with increase in informed decision making about prostate cancer screening
Both web-based and print-based decision aids appear to improve patients' informed decision making about prostate cancer screening up to 13 months later, but does not appear to affect actual screening rates, according to a study by Kathryn L. Taylor, Ph.D., of Georgetown University, Washington, D.C., and colleagues.

Contact: Karen Mallet
km463@georgetown.edu
215-514-9751
The JAMA Network Journals

Public Release: 29-Jul-2013
Antioxidants and Redox Signaling
Cell phones could increase cancer risk
Dr. Yaniv Hamzany of Tel Aviv University has revealed that his new study finds a strong link between heavy cell phone users and higher oxidative stress to all aspects of a human cell, including DNA. Uniquely based on examinations of the saliva of cell phone users, the research provides evidence of a connection between cell phone use and cancer.

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University

Public Release: 29-Jul-2013
JAMA
Major changes urged for cancer screening and treatment
To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as "cancer."

Contact: Elizabeth Fernandez
elizabeth.fernandez@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 29-Jul-2013
Cancer Cell
UK's 'super mouse' yielding major discoveries in cancer research
It appears tiny and inconsequential enough, but the "super mouse" -- created by researchers at the University of Kentucky Markey Cancer Center some six years ago -- has spawned plenty of new research into preventing and/or treating many types of cancer.

Contact: Allison Perry
allison.perry@uky.edu
859-323-2399
University of Kentucky

Public Release: 29-Jul-2013
Proceedings of the National Academy of Sciences
Could sleeping stem cells hold key to treatment of aggressive blood cancer?
Scientists studying an aggressive form of leukaemia have discovered that rather than displacing healthy stem cells in the bone marrow as previously believed, the cancer is putting them to sleep to prevent them forming new blood cells.

Contact: Katrina Coutts
k.coutts@qmul.ac.uk
Queen Mary, University of London

Public Release: 29-Jul-2013
Breast Cancer Research and Treatment
Examination of lymph nodes provides more accurate breast cancer prognosis
After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way. Yet the breast tumour can sometimes appear to be of a less aggressive type while the subtype in the lymph nodes gives a different and more worrying picture.

Contact: Lisa Rydén
lisa.ryden@med.lu.se
46-706-720-923
Lund University

Public Release: 28-Jul-2013
Nature Chemistry
Breakthrough in detecting DNA mutations could help treat tuberculosis, cancer
Researchers at the University of Washington and Rice University have developed a new method that can look at a specific segment of DNA and pinpoint a single mutation, which could help diagnose and treat diseases such as cancer and tuberculosis.

Contact: Michelle Ma
mcma@uw.edu
206-543-2580
University of Washington

Public Release: 28-Jul-2013
Nature Nanotechnology
Molecular robots can help researchers build more targeted therapeutics
Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs, by using molecular "robots" to hone in on more specific populations of cells.
National Institutes of Health, National Science Foundation, Lymphoma and Leukemia Foundation

Contact: Phyllis Fisher
phyllis.fisher@gmail.com
212-606-1724
Hospital for Special Surgery

Public Release: 26-Jul-2013
Proceedings of the National Academy of Sciences
Singapore scientists discover new drug targets for aggressive breast cancer
Scientists at A*STAR's Genome Institute of Singapore led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS.
A*STAR

Contact: Winnie Lim
limcp2@gis.a-star.edu.sg
65-680-88013
Agency for Science, Technology and Research (A*STAR), Singapore

Public Release: 26-Jul-2013
Journal of the National Cancer Institute
HIV-associated lymphoma survival has not improved during the antiretroviral therapy era
Stable survival rates were observed for HIV-associated lymphoma patients during the antiretroviral therapy era in the US, according to a new study published July 26 in the Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
919-677-2697
Journal of the National Cancer Institute

Public Release: 25-Jul-2013
Journal of Thoracic Oncology
Effect of obesity on patients with advanced non-small cell lung cancer
Obesity increases health risks for many things. Researchers wanted to know the impact of obesity on outcomes of patients with advanced non-small cell lung cancer. In the September issue of the International Association for the Study of Lung Cancer's journal, the Journal of Thoracic Oncology, researchers conclude that obese patients had superior outcomes early on in the study, but then experienced increased hazards.

Contact: Kristal Griffith
Kristal.Griffith@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer

Showing releases 26-50 out of 1216.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

  Search News Releases

     

 

 

EurekAlert!